Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: AJR Am J Roentgenol. 2013 Oct;201(4):811–824. doi: 10.2214/AJR.12.10240

Fig. 6. 50-year-old woman with multiple liver metastatic lesions from pancreatic neuroendocrine tumor treated with sunitinib.

Fig. 6

A, Axial contrast-enhanced CT image obtained before sunitinib treatment shows two solid masses (arrows) in liver.

B, Axial contrast-enhanced CT image obtained 6 months after sunitinib treatment shows masses (arrowheads) are larger. However, overall tumor attenuation and enhancing solid component have decreased, suggesting cystic change responding to treatment.